» Articles » PMID: 1425926

Selective and Differential Binding of Interleukin (IL)-1 Alpha, IL-1 Beta, IL-2 and IL-6 to Glycosaminoglycans

Overview
Journal Eur J Immunol
Date 1992 Nov 1
PMID 1425926
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to acidic polysaccharides was investigated by affinity chromatography of the recombinant, radioiodinated interleukins on columns of immobilized polysaccharide. Each interleukin showed selective binding retention. Overall heparin bound all four interleukins significantly, whereas chondroitin sulfate provided little retention. IL-1 alpha and IL-1 beta showed differential binding, with only the latter binding to hyaluronic acid. IL-2 was virtually completely retained on fucoidan. Noniodinated recombinant IL-2 bound similarly to fucoidan, and fucoidan was found to sequester IL-2 activity in a bioassay employing IL-2-dependent CTLL cells. In all other cases tested, interleukin retention was partial, implying that interleukin binding sites are sparsely distributed along the polysaccharide chains. These findings suggest that during the immune response, interleukins will tend to be retained at sites of secretion by interaction with glycosaminoglycans in the extracellular matrix and on cell surfaces.

Citing Articles

Tipping-point transition from transient to persistent inflammation in pancreatic islets.

Holst-Hansen T, Nielsen P, Jensen M, Mandrup-Poulsen T, Trusina A NPJ Syst Biol Appl. 2024; 10(1):102.

PMID: 39266581 PMC: 11393080. DOI: 10.1038/s41540-024-00427-4.


Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis.

Piszczatowski R, Bulow H, Steidl U Blood. 2024; 143(25):2571-2587.

PMID: 38639475 PMC: 11830984. DOI: 10.1182/blood.2023022736.


The Effect of Heparin and Other Exogenous Glycosaminoglycans (GAGs) in Reducing IL-1β-Induced Pro-Inflammatory Cytokine IL-8 and IL-6 mRNA Expression and the Potential Role for Reducing Inflammation.

Jafri M, Li L, Liang B, Luo M Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543157 PMC: 10976005. DOI: 10.3390/ph17030371.


Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates.

Zabihi F, Cherri M, Guo X, Rancan F, Schumacher F, Mohammadifar E Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38256910 PMC: 10821331. DOI: 10.3390/ph17010077.


Defining the versican interactome in lung health and disease.

Tang F, Brune J, Chang M, Reeves S, Altemeier W, Frevert C Am J Physiol Cell Physiol. 2022; 323(2):C249-C276.

PMID: 35649251 PMC: 9291419. DOI: 10.1152/ajpcell.00162.2022.